Lux Capital, established in 2000, is a New York-based venture capital firm managing over $4 billion in assets. It invests in early-stage and growth companies at the intersection of technology and sciences, focusing on sectors such as biochemistry, material science, electronics, infrastructure, and aerospace. Lux actively supports entrepreneurs, having helped build over 20 companies from scratch, and employs a strategy that enhances portfolio companies' connectivity, insights, and industry leadership.
Jericho Security specializes in cybersecurity, focusing on protecting businesses from emerging threats posed by generative AI. The company's core product, cyberGPT, is a proprietary generative AI that simulates real-world cyberattacks, aids in developing new defenses, and provides personalized training to enhance cybersecurity efficiency and prevent potential threats.
ConductorAI
Series A in 2025
ConductorAI specializes in AI-driven compliance solutions for government agencies. Its platform attributes work to relevant policies and procedures, connects model outputs with primary source materials, surfaces existing policies and procedures within workflows, and evaluates models. This helps agencies streamline processes, navigate paperwork, and ensure compliance.
Together AI
Series B in 2025
Together AI is a cloud-based platform designed for constructing open-source generative AI and infrastructure for developing AI models. The company contributes cutting-edge open-source research, models, and datasets to push the boundaries of AI forward. Through its decentralized cloud services, developers and researchers at organizations of various scales are empowered to train, refine, and deploy generative AI models.
Frontera Health
Seed Round in 2025
Frontera Health is changing autism care in underprivileged regions with AI-powered tools that assist physicians in evaluating and treating children with autism and related diseases.
Lanai
Seed Round in 2025
Lanai provides an AI-driven empowerment platform to help enterprises discover, protect, and accelerate human-AI collaboration. It offers a suite of tools designed to enhance developer productivity, focusing on improving the workflow for software teams. Its platform provides features that enable better project management, task coordination, and real-time collaboration.
Bluenote Health
Venture Round in 2024
Bluenote Health operates as an AI platform for life sciences.
Fiddler AI
Series B in 2024
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.
Enveda Biosciences
Series C in 2024
Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.
Shiru
Series B in 2024
Shiru, Inc. is a food technology company based in Oakland, California, established in 2019. The company specializes in developing and producing edible proteins aimed at replacing dairy products and eggs in the food industry. By leveraging artificial intelligence and computational design, Shiru creates enhanced proteins that contribute to sustainable food production. The company's focus on using bioinformatics and precision biology allows it to discover novel natural proteins, thereby enabling clients to replace harmful ingredients with healthier alternatives.
Physical Intelligence
Series A in 2024
Physical Intelligence is a technology company specializing in integrating artificial intelligence with robotics and physical devices. It develops foundational models and learning algorithms to enable robots and other physical devices to perform a wide range of tasks across various industries.
Mendaera
Series B in 2024
Mendaera is a medtech startup dedicated to advancing healthcare technologies, particularly through the development of surgical robots and diagnostic tools. The company aims to digitize clinical judgment and technical expertise, ensuring that high-quality care is accessible to all patients in various care settings. Mendaera's platform, currently under development, integrates robotics, artificial intelligence, real-time imaging, and connectivity to facilitate precise and consistent point-of-care interventions. By aiding physicians in image acquisition and interpretation, Mendaera seeks to eliminate barriers in the patient journey, accelerate recovery, and reduce healthcare costs, thereby enhancing the capabilities of healthcare professionals in performing medical procedures effectively.
11x
Series A in 2024
11x is a technology company that specializes in developing autonomous digital workers aimed at optimizing organizational processes, particularly in go-to-market operations. By automating specific roles, 11x enables businesses to streamline their hiring budgets and enhance productivity. The company's primary offerings include Alice, an AI-powered sales development representative, and Jordan, both of which are part of its platform that provides customizable artificial intelligence workers. These digital workers are designed to perform tasks traditionally handled by knowledge workers, allowing organizations to improve efficiency and scale effectively as they grow.
Magie
Seed Round in 2024
Magie is an innovative financial application that operates as WhatsApp's first smart account, simplifying the process of bill payments. By leveraging artificial intelligence, Magie allows users to pay invoices directly through WhatsApp, enabling seamless communication via messages, audio, or photographs without the need to navigate through a separate app. This application manages invoices and scheduled payments by interpreting instructions sent through various formats, thus providing users with an efficient way to oversee their financial transactions. Magie's approach emphasizes convenience and time-saving, catering to individuals who value efficiency in managing their finances.
Infinite Reality
Funding Round in 2024
Infinite Reality is a company focused on creating immersive digital experiences that enhance the relationship between audiences, creators, and brands. By leveraging advanced technologies such as artificial intelligence and spatial computing, Infinite Reality offers platforms that allow businesses to build networks within digital ecosystems, ensuring they retain control over content distribution, audience engagement, and monetization strategies. The company specializes in developing world-class Metaverse experiences, supported by a robust entertainment division that produces original content and live events from its expansive Los Angeles studio. Additionally, its Agency services foster audience cultivation, while its portfolio of digital brands, including esports organizations and influencer management agencies, helps elevate awareness and adoption of emerging Web3 opportunities. Through these various initiatives, Infinite Reality aims to redefine the boundaries of connected digital environments.
Kinetic Automation
Series B in 2024
Kinetic Automation is transforming the automotive repair industry by developing an advanced infrastructure that integrates hardware, robotics, software, and artificial intelligence. The company focuses on providing mobility services specifically for electric and autonomous vehicles through its automated repair centers. Utilizing precision technology powered by machine learning, Kinetic aims to deliver rapid, accurate, and predictable maintenance solutions. Its innovative approach positions Kinetic as a key player in the future of automotive servicing, facilitating essential support for electric vehicle owners and enhancing the overall efficiency of vehicle maintenance.
Maven AGI
Series A in 2024
Maven AGI is a technology company specializing in modern artificial intelligence solutions. It focuses on revolutionizing customer support by employing AI to reduce costs, enhance speed and quality, and boost operational efficiency. The company's AI solutions empower teams to increase productivity and focus on tasks that require human expertise. Additionally, Maven AGI offers services such as customer acquisition strategy and operational planning. With a team of 50 employees across various roles, the company aims to transform customer support experiences.
LabGenius
Series B in 2024
LabGenius Ltd is a biopharmaceutical company based in London that focuses on discovering new biological molecules through the integration of artificial intelligence, automation, and synthetic DNA. Founded in 2012, the company has developed a robotic platform known as EVA, which acts as a robot scientist capable of designing, conducting, and learning from its own experiments. LabGenius specializes in developing next-generation protein therapeutics aimed at addressing unmet medical needs, including conditions like Inflammatory Bowel Disease. Their innovative approach utilizes advanced machine learning and synthetic biology to engineer the properties of protein drugs, enhancing attributes such as protease stability and tissue penetration. This technology enables the efficient creation of protein therapeutics, providing physicians with access to cutting-edge treatments developed through robotic automation.
Xaira Therapeutics
Venture Round in 2024
Xaira Therapeutics is an integrated biotechnology company focused on revolutionizing drug discovery and development through the application of artificial intelligence. Headquartered in the San Francisco Bay Area, Xaira combines expertise in machine learning, extensive biological and clinical data generation, and robust therapeutic product development. By harnessing advanced AI techniques, the company aims to enhance the understanding of biological processes and improve the effectiveness of therapies. Xaira's approach encompasses all stages of drug discovery, striving to transform how diseases are treated and enabling clients to deliver innovative therapeutic solutions.
Ripcord
Venture Round in 2024
Ripcord, Inc. is a robotic digitization company that specializes in automating the management of paper records. Founded in 2014 and headquartered in Los Angeles, California, Ripcord develops a platform that utilizes advanced technologies, including artificial intelligence, machine learning, and vision-guided robotics, to create digital twins of physical documents. Its flagship solution, Canopy, captures, enriches, and organizes critical content, allowing enterprises to enhance their business processes with improved speed, quality, and accuracy. Formerly known as Ripcord Digital, Inc., the company rebranded in June 2017 to reflect its focus on innovative digitization solutions.
Collaborative Robotics
Series B in 2024
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.
Together AI
Series A in 2024
Together AI is a cloud-based platform designed for constructing open-source generative AI and infrastructure for developing AI models. The company contributes cutting-edge open-source research, models, and datasets to push the boundaries of AI forward. Through its decentralized cloud services, developers and researchers at organizations of various scales are empowered to train, refine, and deploy generative AI models.
Physical Intelligence
Seed Round in 2024
Physical Intelligence is a technology company specializing in integrating artificial intelligence with robotics and physical devices. It develops foundational models and learning algorithms to enable robots and other physical devices to perform a wide range of tasks across various industries.
Sakana AI
Seed Round in 2024
Sakana AI is a research-focused company dedicated to developing innovative foundation models inspired by nature. It specializes in creating an AI model capable of generating text, images, video, code, and multimedia, facilitating collaborative research and development in generative AI. The company's AI development process emphasizes evolution and collective intelligence.
Inductive Bio
Seed Round in 2023
Inductive Bio specializes in providing a machine learning platform that enhances the compound optimization process for drug development. The company focuses on addressing ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) challenges by building comprehensive datasets and machine learning models. This enables scientists to efficiently identify and refine small molecule compounds, transforming initial candidates into viable leads more rapidly and with improved properties. By streamlining the optimization process, Inductive Bio supports the development of new therapeutics, ultimately contributing to advancements in the pharmaceutical industry.
Armada
Series A in 2023
Armada is a developer of an edge computing platform that aims to enhance connectivity and facilitate real-time data processing for individuals and businesses. The company focuses on closing the digital gap by providing a resilient, secure, and scalable infrastructure, complemented by compatible software components. This integrated approach enables users to efficiently manage and optimize their data through a single control plane, ultimately supporting improved decision-making and the effective use of artificial intelligence tools.
Factory
Seed Round in 2023
Factory is a technology company that develops an AI-driven platform for software engineering. This platform reviews code, identifies and fixes bugs, answers queries, and handles routine tasks such as code review and refactoring, allowing engineers to focus on complex problems.
Modal Labs
Series A in 2023
Modal Labs is a technology company that specializes in machine learning software designed to facilitate code execution in the cloud. Its platform allows users to deploy machine learning models, run massively parallel compute jobs, manage task queues, and host web applications. By utilizing containers, Modal's software automates the provisioning of compute instances, hardware accelerators, and cloud storage. This enables data science teams to concentrate on developing their models and applications without the burden of managing intricate infrastructure, thereby enhancing efficiency and performance in cloud-based computing environments.
Kinetic Automation
Series A in 2023
Kinetic Automation is transforming the automotive repair industry by developing an advanced infrastructure that integrates hardware, robotics, software, and artificial intelligence. The company focuses on providing mobility services specifically for electric and autonomous vehicles through its automated repair centers. Utilizing precision technology powered by machine learning, Kinetic aims to deliver rapid, accurate, and predictable maintenance solutions. Its innovative approach positions Kinetic as a key player in the future of automotive servicing, facilitating essential support for electric vehicle owners and enhancing the overall efficiency of vehicle maintenance.
Delphi
Seed Round in 2023
Delphi is a digital cloning platform designed to capture and replicate individual thoughts, insights, and experiences. This innovative platform allows users to access personalized knowledge and advice tailored to their unique perspectives. By harnessing the information and opinions of various individuals, Delphi facilitates personalized learning and development, enabling users to benefit from the expertise available across the internet. The platform aims to make valuable insights readily available to others, enhancing their decision-making and personal growth.
Mendaera
Series A in 2023
Mendaera is a medtech startup dedicated to advancing healthcare technologies, particularly through the development of surgical robots and diagnostic tools. The company aims to digitize clinical judgment and technical expertise, ensuring that high-quality care is accessible to all patients in various care settings. Mendaera's platform, currently under development, integrates robotics, artificial intelligence, real-time imaging, and connectivity to facilitate precise and consistent point-of-care interventions. By aiding physicians in image acquisition and interpretation, Mendaera seeks to eliminate barriers in the patient journey, accelerate recovery, and reduce healthcare costs, thereby enhancing the capabilities of healthcare professionals in performing medical procedures effectively.
Jericho Security
Pre Seed Round in 2023
Jericho Security specializes in cybersecurity, focusing on protecting businesses from emerging threats posed by generative AI. The company's core product, cyberGPT, is a proprietary generative AI that simulates real-world cyberattacks, aids in developing new defenses, and provides personalized training to enhance cybersecurity efficiency and prevent potential threats.
Together AI
Seed Round in 2023
Together AI is a cloud-based platform designed for constructing open-source generative AI and infrastructure for developing AI models. The company contributes cutting-edge open-source research, models, and datasets to push the boundaries of AI forward. Through its decentralized cloud services, developers and researchers at organizations of various scales are empowered to train, refine, and deploy generative AI models.
Mythic
Venture Round in 2023
Mythic Inc. is a technology company that designs and develops silicon chips and artificial intelligence processing units (IPUs) for a wide range of applications, from consumer electronics and wearables to autonomous vehicles and robotic drones. Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic specializes in analog matrix processors that utilize unique compute-in-memory technology. Their products, including the M1076 Analog Matrix Processor and various PCIe and M.2 cards, integrate AI capabilities directly into compact chips, enabling desktop-level processing power in smaller devices. The company emphasizes its expertise in neural networks, processor architecture, and software design to deliver efficient AI solutions while maintaining performance, power efficiency, and accuracy in real-world environments.
Armada
Seed Round in 2023
Armada is a developer of an edge computing platform that aims to enhance connectivity and facilitate real-time data processing for individuals and businesses. The company focuses on closing the digital gap by providing a resilient, secure, and scalable infrastructure, complemented by compatible software components. This integrated approach enables users to efficiently manage and optimize their data through a single control plane, ultimately supporting improved decision-making and the effective use of artificial intelligence tools.
Thatch
Seed Round in 2023
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.
Thatch
Pre Seed Round in 2023
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.
Paradigm
Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.
Osmo
Venture Round in 2023
Osmo is a company that combines artificial intelligence with olfactory science to create a platform that gives computers a sense of smell. Initially focused on the fragrance industry, Osmo develops aroma molecules for products such as perfumes, shampoos, lotions, and candles. In addition to enhancing consumer experiences, the technology has the potential to detect diseases earlier and track pandemics, ultimately aiming to improve overall health and well-being. By addressing these challenges, Osmo seeks to revolutionize how scent is integrated into everyday life and its implications for human health.
Enveda Biosciences
Series B in 2022
Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.
Runway
Series C in 2022
Runway is an applied AI research company established in 2024, specializing in developing innovative tools that integrate artificial intelligence into creative processes. The company offers a video editing platform designed for professionals in art, entertainment, and design. Its technology leverages original image and video creation methods, allowing users to manipulate and edit content intuitively using text inputs. This approach simplifies the video creation process for artists, designers, and filmmakers, enabling them to express their creativity more effectively. Runway's mission is to enhance human creativity through advanced AI capabilities, facilitating seamless interactions between technology and artistic expression.
Stairwell
Series B in 2022
Stairwell, Inc., founded in 2019 and headquartered in Mountain View, California, specializes in cybersecurity solutions through its Software as a Service (SaaS) platform. The company focuses on Automated Threat Detection and Response, providing tools that enable security teams to identify and address potential threats efficiently. By treating all files as suspicious and preserving them as evidence, Stairwell accelerates threat analysis, allowing organizations to quickly assess their security status in response to emerging threats. Its technology incorporates artificial intelligence and machine learning to deliver automated reports that indicate whether an organization has been compromised and, if so, outlines the details of the incident. This innovative approach enhances the capabilities of security personnel, streamlining the processes of threat evaluation and response. Stairwell has garnered recognition for its innovative contributions to the cybersecurity landscape, supported by prominent investors and partners.
Anagenex
Series A in 2022
Anagenex is a seed stage biotechnology company focused on advancing drug discovery through its innovative platform. The company aims to tackle challenging pharmaceutical targets by utilizing a technology that combines machine learning with DNA-encoded libraries. This approach allows for the rapid analysis of compounds and the generation of extensive data sets, facilitating parallel biochemical experiments. By leveraging proprietary artificial intelligence models, Anagenex enables researchers to efficiently develop new small molecule drugs for medically significant applications.
LatchBio
Series A in 2022
LatchBio is a company that specializes in developing a bioinformatics platform aimed at supporting cell and gene therapy startups. Established in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, LatchBio provides an open-source machine learning and cloud infrastructure tailored for the biotech sector. Its platform modernizes the computing capabilities available to biotech labs by offering custom workflows, pipelines, and machine learning models that can be utilized across various scales. This infrastructure enables scientists to efficiently create bioinformatic queries without requiring extensive command-line knowledge or dealing with complex setups. By streamlining data integration and processing, LatchBio helps biotech companies accelerate therapeutic discovery and reduce engineering costs.
Anduril Industries
Series E in 2022
Anduril Industries, Inc. is a defense technology company that designs, manufactures, and deploys advanced hardware and software products to address complex national security challenges faced by the United States and its allies. Founded in 2017 and headquartered in Irvine, California, with additional offices in Washington, D.C., and Seattle, the company employs top technical talent to create innovative solutions. Its offerings include the Lattice Platform, which integrates artificial intelligence, computer vision, and machine learning to provide a cohesive operational picture; the Sentry Tower, which collects data across the electromagnetic spectrum; and the Ghost sUAS, a man-portable unmanned aerial system capable of performing various missions autonomously. Additionally, Anduril develops the Anvil sUAS, designed for precise drone threat interception while providing visual feedback for human operators. Through its cutting-edge technology, Anduril aims to enhance defense capabilities and support frontline personnel in safeguarding national interests.
Alife
Series A in 2022
Alife is a health technology company that focuses on using artificial intelligence to enhance the success rates of pregnancy for individuals undergoing fertility treatments. Founded in 2020 by Paxton Maeder-York and based in San Francisco, California, Alife aims to assist physicians in selecting the healthiest embryos through advanced deep learning and software development. By connecting fertility specialists with patients, the company seeks to improve the overall chances of achieving healthy pregnancies, ultimately supporting its mission of helping people have healthy children.
OpenSpace
Series D in 2022
OpenSpace is a technology company founded in 2017 and headquartered in San Francisco, California, that specializes in automated 360-degree video capture and mapping for the construction industry. Its core product captures images every half-second and automatically integrates them with project plans, offering builders a comprehensive view of job sites from preconstruction to operations. By employing artificial intelligence, OpenSpace enables the creation of navigable photo representations of construction sites, significantly enhancing data capture speed compared to traditional methods. Additionally, the company's Clear Sight product suite provides AI-powered analytics to quantify project progress, facilitating collaboration and risk reduction in construction workflows.
Anagenex
Seed Round in 2022
Anagenex is a seed stage biotechnology company focused on advancing drug discovery through its innovative platform. The company aims to tackle challenging pharmaceutical targets by utilizing a technology that combines machine learning with DNA-encoded libraries. This approach allows for the rapid analysis of compounds and the generation of extensive data sets, facilitating parallel biochemical experiments. By leveraging proprietary artificial intelligence models, Anagenex enables researchers to efficiently develop new small molecule drugs for medically significant applications.
Shiru
Series A in 2021
Shiru, Inc. is a food technology company based in Oakland, California, established in 2019. The company specializes in developing and producing edible proteins aimed at replacing dairy products and eggs in the food industry. By leveraging artificial intelligence and computational design, Shiru creates enhanced proteins that contribute to sustainable food production. The company's focus on using bioinformatics and precision biology allows it to discover novel natural proteins, thereby enabling clients to replace harmful ingredients with healthier alternatives.
Clarifai
Series C in 2021
Clarifai, Inc. is a prominent provider of advanced artificial intelligence solutions specializing in image recognition, natural language processing, and audio recognition. Founded in 2013 by Matt Zeiler, Ph.D., the company develops a deep learning platform that enables organizations to convert unstructured data—such as images, videos, text, and audio—into structured data efficiently and accurately. Clarifai's image recognition technology is capable of detecting near-duplicates, categorizing objects, and tagging images, while also allowing users to search for similar images within extensive uncategorized collections through a combination of semantic and visual similarity. Additionally, the company offers a labeling tool called Labeler, which aids in dataset labeling, AI training, and model auto-scaling in production environments. Headquartered in New York, with an office in Tallinn, Estonia, Clarifai employs a distributed team across various countries, including the United States, Canada, Argentina, and India.
MosaicML
Venture Round in 2021
MosaicML specializes in developing software infrastructure and algorithms aimed at enhancing the efficiency of training large language models and neural networks. The company focuses on employing algorithmic techniques, such as sparsity and network pruning, to optimize the training process. By doing so, MosaicML enables users to train large-scale artificial intelligence models more efficiently and cost-effectively within their secure environments, utilizing their proprietary data. This approach not only improves training speed and model quality but also reduces overall costs associated with model development.
Replai
Seed Round in 2021
Replai is a technology company that has developed a creative insights platform focused on the esports industry. Founded in 2019 and based in Porto, Portugal, with additional offices in San Francisco and London, Replai leverages artificial intelligence to create short videos from live esports streams. The platform automates the generation of highlights and adapts content for brands, helping them optimize the performance and engagement of their video creatives. Replai addresses a key challenge for marketers by using AI algorithms to enhance creative strategies, enabling brands and mobile app companies to maximize their growth and sponsorship value. The company has established partnerships with prominent global brands, positioning itself as a leader in the intersection of esports and marketing technology.
LatchBio
Seed Round in 2021
LatchBio is a company that specializes in developing a bioinformatics platform aimed at supporting cell and gene therapy startups. Established in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, LatchBio provides an open-source machine learning and cloud infrastructure tailored for the biotech sector. Its platform modernizes the computing capabilities available to biotech labs by offering custom workflows, pipelines, and machine learning models that can be utilized across various scales. This infrastructure enables scientists to efficiently create bioinformatic queries without requiring extensive command-line knowledge or dealing with complex setups. By streamlining data integration and processing, LatchBio helps biotech companies accelerate therapeutic discovery and reduce engineering costs.
Statespace
Series C in 2021
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.
DoNotPay
Series B in 2021
DoNotPay, Inc. is a technology company based in San Francisco, California, founded in 2015. It operates a platform that provides legal information and self-help services through an artificial intelligence-driven chatbot. This application assists users in a variety of legal matters, enabling them to file lawsuits, claim awards, challenge corporations, and navigate bureaucratic processes. It also helps users cancel free trials, appeal bank fees, and address traffic violations, among other issues. DoNotPay's services are available to residents in the United States, Puerto Rico, and the United Kingdom, aiming to democratize access to legal resources and empower individuals to manage their legal challenges efficiently and at no cost.
Enveda Biosciences
Series A in 2021
Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.
Primer
Series C in 2021
Primer Technologies, Inc., established in 2014 and headquartered in San Francisco, specializes in developing software that leverages machine learning and natural language processing to analyze vast amounts of textual data across multiple languages. Its platform automates the parsing and collation of documents, uncovering insights and generating reports comparable to those produced by human analysts. This enables governments and corporations to better understand and monitor global information, facilitating informed decision-making.
Anduril Industries
Series D in 2021
Anduril Industries, Inc. is a defense technology company that designs, manufactures, and deploys advanced hardware and software products to address complex national security challenges faced by the United States and its allies. Founded in 2017 and headquartered in Irvine, California, with additional offices in Washington, D.C., and Seattle, the company employs top technical talent to create innovative solutions. Its offerings include the Lattice Platform, which integrates artificial intelligence, computer vision, and machine learning to provide a cohesive operational picture; the Sentry Tower, which collects data across the electromagnetic spectrum; and the Ghost sUAS, a man-portable unmanned aerial system capable of performing various missions autonomously. Additionally, Anduril develops the Anvil sUAS, designed for precise drone threat interception while providing visual feedback for human operators. Through its cutting-edge technology, Anduril aims to enhance defense capabilities and support frontline personnel in safeguarding national interests.
Fiddler AI
Series B in 2021
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.
Dyno Therapeutics
Series A in 2021
Dyno Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative adeno-associated virus (AAV) vectors for gene therapy applications. Founded in 2018, the company employs an artificial intelligence-powered platform that integrates next-generation DNA synthesis, high-throughput sequencing, and machine learning. This advanced approach allows Dyno Therapeutics to design and optimize cell-targeting capsids, which are crucial for the effective and safe delivery of gene therapies. By leveraging its technology, the company aims to provide medical researchers with novel AAV vectors that enhance the efficacy of in vivo therapeutic solutions.
Alife
Seed Round in 2021
Alife is a health technology company that focuses on using artificial intelligence to enhance the success rates of pregnancy for individuals undergoing fertility treatments. Founded in 2020 by Paxton Maeder-York and based in San Francisco, California, Alife aims to assist physicians in selecting the healthiest embryos through advanced deep learning and software development. By connecting fertility specialists with patients, the company seeks to improve the overall chances of achieving healthy pregnancies, ultimately supporting its mission of helping people have healthy children.
OpenSpace
Series C in 2021
OpenSpace is a technology company founded in 2017 and headquartered in San Francisco, California, that specializes in automated 360-degree video capture and mapping for the construction industry. Its core product captures images every half-second and automatically integrates them with project plans, offering builders a comprehensive view of job sites from preconstruction to operations. By employing artificial intelligence, OpenSpace enables the creation of navigable photo representations of construction sites, significantly enhancing data capture speed compared to traditional methods. Additionally, the company's Clear Sight product suite provides AI-powered analytics to quantify project progress, facilitating collaboration and risk reduction in construction workflows.
DeepSpin
Convertible Note in 2021
DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.
Bifrost AI
Seed Round in 2021
Bifrost is a developer of a Generative 3D platform for creatives to create custom virtual worlds. It generates synthetic training data using three-dimensional graphics to simulate real-life scenarios. These datasets help teach AI systems to handle new tasks, environments, and challenges, while also validating their performance and reliability across thousands of automatically generated scenarios.
Runway
Series A in 2020
Runway is an applied AI research company established in 2024, specializing in developing innovative tools that integrate artificial intelligence into creative processes. The company offers a video editing platform designed for professionals in art, entertainment, and design. Its technology leverages original image and video creation methods, allowing users to manipulate and edit content intuitively using text inputs. This approach simplifies the video creation process for artists, designers, and filmmakers, enabling them to express their creativity more effectively. Runway's mission is to enhance human creativity through advanced AI capabilities, facilitating seamless interactions between technology and artistic expression.
LabGenius
Series A in 2020
LabGenius Ltd is a biopharmaceutical company based in London that focuses on discovering new biological molecules through the integration of artificial intelligence, automation, and synthetic DNA. Founded in 2012, the company has developed a robotic platform known as EVA, which acts as a robot scientist capable of designing, conducting, and learning from its own experiments. LabGenius specializes in developing next-generation protein therapeutics aimed at addressing unmet medical needs, including conditions like Inflammatory Bowel Disease. Their innovative approach utilizes advanced machine learning and synthetic biology to engineer the properties of protein drugs, enhancing attributes such as protease stability and tissue penetration. This technology enables the efficient creation of protein therapeutics, providing physicians with access to cutting-edge treatments developed through robotic automation.
Recursion Pharmaceuticals
Series D in 2020
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.
Auransa
Series A in 2020
Auransa Inc., founded in 2014 and based in Palo Alto, California, is a clinical stage drug development company focused on creating innovative treatments for challenging diseases, including cancer, autoimmune, and neurological disorders. Utilizing a proprietary artificial intelligence platform, Auransa analyzes extensive genomic data from human disease tissues to study molecular subtypes of diseases. This approach allows the company to predict potential drug compounds and identify targets tailored for specific patient populations. Currently, Auransa's internal drug pipeline features a first-in-class investigational new drug for cancer that is undergoing clinical trials. The company actively collaborates with various partners in the biopharma sector to advance its drug development efforts.
OpenSpace
Series B in 2020
OpenSpace is a technology company founded in 2017 and headquartered in San Francisco, California, that specializes in automated 360-degree video capture and mapping for the construction industry. Its core product captures images every half-second and automatically integrates them with project plans, offering builders a comprehensive view of job sites from preconstruction to operations. By employing artificial intelligence, OpenSpace enables the creation of navigable photo representations of construction sites, significantly enhancing data capture speed compared to traditional methods. Additionally, the company's Clear Sight product suite provides AI-powered analytics to quantify project progress, facilitating collaboration and risk reduction in construction workflows.
Anduril Industries
Series C in 2020
Anduril Industries, Inc. is a defense technology company that designs, manufactures, and deploys advanced hardware and software products to address complex national security challenges faced by the United States and its allies. Founded in 2017 and headquartered in Irvine, California, with additional offices in Washington, D.C., and Seattle, the company employs top technical talent to create innovative solutions. Its offerings include the Lattice Platform, which integrates artificial intelligence, computer vision, and machine learning to provide a cohesive operational picture; the Sentry Tower, which collects data across the electromagnetic spectrum; and the Ghost sUAS, a man-portable unmanned aerial system capable of performing various missions autonomously. Additionally, Anduril develops the Anvil sUAS, designed for precise drone threat interception while providing visual feedback for human operators. Through its cutting-edge technology, Anduril aims to enhance defense capabilities and support frontline personnel in safeguarding national interests.
Bifrost AI
Pre Seed Round in 2020
Bifrost is a developer of a Generative 3D platform for creatives to create custom virtual worlds. It generates synthetic training data using three-dimensional graphics to simulate real-life scenarios. These datasets help teach AI systems to handle new tasks, environments, and challenges, while also validating their performance and reliability across thousands of automatically generated scenarios.
Statespace
Series A in 2020
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.
Braid Health
Series A in 2020
Braid Health, Inc., founded in 2018 and headquartered in San Francisco, California, specializes in developing artificial intelligence-driven diagnostic tools for radiology. The company offers an AI-powered diagnostic collaboration platform that enhances the speed, quality, and workflow of radiologists and healthcare providers. By integrating AI diagnostics with the expertise of board-certified radiologists, Braid Health supports real-time quality assurance and facilitates seamless integration with Electronic Health Records (EHR). This innovative approach allows healthcare professionals to deliver accurate diagnoses efficiently, improving overall patient care and access to medical imaging services.
Rosebud AI
Seed Round in 2020
Rosebud AI, Inc. is a San Francisco-based company that specializes in developing software for creating digital avatars and models tailored for various uses. The platform allows users to customize avatars based on demographic factors, age, and style, making it accessible for a wide range of applications. Additionally, Rosebud AI focuses on generating artificial intelligence-driven game assets, simplifying the process of visual content creation for creators. The software enables users to effortlessly produce non-fungible token (NFT) collections without requiring prior experience in smart contracts or web3 technologies. By integrating established computer graphics techniques with advanced AI research, the company also offers tools for animating old photos and enhancing artistic creations, thereby enriching the digital content landscape.
Ripcord
Series B in 2020
Ripcord, Inc. is a robotic digitization company that specializes in automating the management of paper records. Founded in 2014 and headquartered in Los Angeles, California, Ripcord develops a platform that utilizes advanced technologies, including artificial intelligence, machine learning, and vision-guided robotics, to create digital twins of physical documents. Its flagship solution, Canopy, captures, enriches, and organizes critical content, allowing enterprises to enhance their business processes with improved speed, quality, and accuracy. Formerly known as Ripcord Digital, Inc., the company rebranded in June 2017 to reflect its focus on innovative digitization solutions.
Evolv Technology
Series C in 2020
Evolv Technology specializes in AI-based touchless security screening systems that prioritize safety while enhancing the visitor experience. The company's Mosaiq Platform integrates real-time video surveillance with advanced detection capabilities for firearms and explosives, facial recognition, and security analytics, all designed to minimize false alarms. Headquartered in Waltham, Massachusetts, Evolv is led by professionals with extensive backgrounds in security, including experience with the TSA, FBI, CIA, Secret Service, and Homeland Security. The firm offers its products through direct sales and a multi-year security-as-a-service subscription model, which not only provides ongoing value to clients but also fosters predictable revenue streams and opportunities for expansion. Evolv Technology aims to protect both public and private sectors by securing soft targets and vital assets.
Shadow
Seed Round in 2020
Shadow is a community-led application designed to assist in reuniting lost pets with their owners across the United States, with a particular focus on dogs. The platform combines a volunteer network and artificial intelligence technology to enhance the search process. Users can post pictures of their missing pets, which are then matched with images from nearby animal shelters and online sources. Shadow collaborates with shelters and rescue organizations to gather photos of dogs currently in their care, enriching the database of potential matches. Volunteers play a crucial role by reviewing photographs and disseminating missing pet posters through social media, thereby increasing the visibility of lost animals and improving the chances of their safe return.
HumanFirst
Seed Round in 2019
HumanFirst is a developer of an AI-powered software-as-a-service platform that aims to enhance patient-centered clinical trials through the use of precision digital measures, including digital biomarkers and electronic clinical outcome assessments. The platform, recognized as the largest of its kind, provides biopharma companies with valuable insights and validated evidence data to streamline drug development processes. By facilitating the integration of digital health technologies, HumanFirst supports pharmaceutical organizations in improving research efficiency and accelerating the deployment of innovative treatments. The platform has been utilized by 22 of the 25 largest pharmaceutical companies worldwide, underscoring its significance in advancing human-centric research and development.
Orbital Insight
Series D in 2019
Orbital Insight, Inc. is a geospatial analytics company based in Palo Alto, California, established in 2013. The firm develops a cloud-based platform that employs artificial intelligence and machine learning to analyze vast amounts of geospatial data, including satellite imagery, mobile location signals, and other Internet of Things data. This technology enables organizations, including businesses, governments, and NGOs, to gain insights into societal and economic trends that may not be visible to the naked eye. Orbital Insight's products, such as Orbital Insight GO, GO Consumer, and GO Energy, provide users with actionable intelligence regarding infrastructure, supply chain dynamics, and energy resources. By transforming billions of data points into clear, usable information, the company supports data-driven decision-making in various sectors.
Evolv Technology
Series C in 2019
Evolv Technology specializes in AI-based touchless security screening systems that prioritize safety while enhancing the visitor experience. The company's Mosaiq Platform integrates real-time video surveillance with advanced detection capabilities for firearms and explosives, facial recognition, and security analytics, all designed to minimize false alarms. Headquartered in Waltham, Massachusetts, Evolv is led by professionals with extensive backgrounds in security, including experience with the TSA, FBI, CIA, Secret Service, and Homeland Security. The firm offers its products through direct sales and a multi-year security-as-a-service subscription model, which not only provides ongoing value to clients but also fosters predictable revenue streams and opportunities for expansion. Evolv Technology aims to protect both public and private sectors by securing soft targets and vital assets.
Shiru
Seed Round in 2019
Shiru, Inc. is a food technology company based in Oakland, California, established in 2019. The company specializes in developing and producing edible proteins aimed at replacing dairy products and eggs in the food industry. By leveraging artificial intelligence and computational design, Shiru creates enhanced proteins that contribute to sustainable food production. The company's focus on using bioinformatics and precision biology allows it to discover novel natural proteins, thereby enabling clients to replace harmful ingredients with healthier alternatives.
Fiddler AI
Venture Round in 2019
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.
LabGenius
Series A in 2019
LabGenius Ltd is a biopharmaceutical company based in London that focuses on discovering new biological molecules through the integration of artificial intelligence, automation, and synthetic DNA. Founded in 2012, the company has developed a robotic platform known as EVA, which acts as a robot scientist capable of designing, conducting, and learning from its own experiments. LabGenius specializes in developing next-generation protein therapeutics aimed at addressing unmet medical needs, including conditions like Inflammatory Bowel Disease. Their innovative approach utilizes advanced machine learning and synthetic biology to engineer the properties of protein drugs, enhancing attributes such as protease stability and tissue penetration. This technology enables the efficient creation of protein therapeutics, providing physicians with access to cutting-edge treatments developed through robotic automation.
Fiddler AI
Series A in 2019
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.
Anduril Industries
Series B in 2019
Anduril Industries, Inc. is a defense technology company that designs, manufactures, and deploys advanced hardware and software products to address complex national security challenges faced by the United States and its allies. Founded in 2017 and headquartered in Irvine, California, with additional offices in Washington, D.C., and Seattle, the company employs top technical talent to create innovative solutions. Its offerings include the Lattice Platform, which integrates artificial intelligence, computer vision, and machine learning to provide a cohesive operational picture; the Sentry Tower, which collects data across the electromagnetic spectrum; and the Ghost sUAS, a man-portable unmanned aerial system capable of performing various missions autonomously. Additionally, Anduril develops the Anvil sUAS, designed for precise drone threat interception while providing visual feedback for human operators. Through its cutting-edge technology, Anduril aims to enhance defense capabilities and support frontline personnel in safeguarding national interests.
Caper
Series A in 2019
Caper is a company that develops an AI-powered shopping cart aimed at enhancing the grocery shopping experience. By integrating technologies such as image recognition and sensor fusion, Caper's smart cart allows shoppers to conveniently add items to their cart and self-checkout without the need for cashiers. This plug-and-play system captures images of items and scans barcodes, facilitating an automated checkout process. Caper's innovative approach seeks to transform physical retail by enabling existing grocery stores to adopt a kiosk-less shopping experience, thereby streamlining operations and improving customer satisfaction.
OpenSpace
Series A in 2019
OpenSpace is a technology company founded in 2017 and headquartered in San Francisco, California, that specializes in automated 360-degree video capture and mapping for the construction industry. Its core product captures images every half-second and automatically integrates them with project plans, offering builders a comprehensive view of job sites from preconstruction to operations. By employing artificial intelligence, OpenSpace enables the creation of navigable photo representations of construction sites, significantly enhancing data capture speed compared to traditional methods. Additionally, the company's Clear Sight product suite provides AI-powered analytics to quantify project progress, facilitating collaboration and risk reduction in construction workflows.
Statespace
Seed Round in 2019
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.
Recursion Pharmaceuticals
Series C in 2019
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.
Mythic
Series B in 2019
Mythic Inc. is a technology company that designs and develops silicon chips and artificial intelligence processing units (IPUs) for a wide range of applications, from consumer electronics and wearables to autonomous vehicles and robotic drones. Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic specializes in analog matrix processors that utilize unique compute-in-memory technology. Their products, including the M1076 Analog Matrix Processor and various PCIe and M.2 cards, integrate AI capabilities directly into compact chips, enabling desktop-level processing power in smaller devices. The company emphasizes its expertise in neural networks, processor architecture, and software design to deliver efficient AI solutions while maintaining performance, power efficiency, and accuracy in real-world environments.
Veo Robotics
Series A in 2019
Veo Robotics, Inc., founded in 2016 and based in Waltham, Massachusetts, specializes in developing robotics systems that enhance manufacturing processes. The company focuses on creating industrial automation products that allow high-performance robots to work collaboratively and safely alongside human workers. By integrating advanced computer vision, 3D sensing, and artificial intelligence, Veo Robotics' products aim to create more flexible, productive, and efficient manufacturing workcells. Their proprietary algorithms and distributed sensing technologies enable clients to improve productivity while reducing operating costs in both manufacturing and logistics environments.
Runway
Seed Round in 2018
Runway is an applied AI research company established in 2024, specializing in developing innovative tools that integrate artificial intelligence into creative processes. The company offers a video editing platform designed for professionals in art, entertainment, and design. Its technology leverages original image and video creation methods, allowing users to manipulate and edit content intuitively using text inputs. This approach simplifies the video creation process for artists, designers, and filmmakers, enabling them to express their creativity more effectively. Runway's mission is to enhance human creativity through advanced AI capabilities, facilitating seamless interactions between technology and artistic expression.
Auris Health
Series E in 2018
Auris Health, Inc. is a medical technology company based in Redwood City, California, that specializes in the development of robotic systems for diagnostic and therapeutic procedures. Founded in 2007, the company is known for its Monarch Platform, which enhances endoscopic procedures by utilizing flexible robotics, advanced imaging technology, and micro-instrumentation. This platform allows for minimally invasive access to the body through natural openings using small cameras and tools, thereby improving patient outcomes and potentially reducing healthcare costs. Additionally, Auris Health is working on a dual-arm microsurgical system designed for ophthalmic surgery, further expanding its focus on innovative robotic solutions for various medical applications. Auris Health operates as a subsidiary of Johnson & Johnson.
Primer
Series B in 2018
Primer Technologies, Inc., established in 2014 and headquartered in San Francisco, specializes in developing software that leverages machine learning and natural language processing to analyze vast amounts of textual data across multiple languages. Its platform automates the parsing and collation of documents, uncovering insights and generating reports comparable to those produced by human analysts. This enables governments and corporations to better understand and monitor global information, facilitating informed decision-making.
Braid Health
Seed Round in 2018
Braid Health, Inc., founded in 2018 and headquartered in San Francisco, California, specializes in developing artificial intelligence-driven diagnostic tools for radiology. The company offers an AI-powered diagnostic collaboration platform that enhances the speed, quality, and workflow of radiologists and healthcare providers. By integrating AI diagnostics with the expertise of board-certified radiologists, Braid Health supports real-time quality assurance and facilitates seamless integration with Electronic Health Records (EHR). This innovative approach allows healthcare professionals to deliver accurate diagnoses efficiently, improving overall patient care and access to medical imaging services.
Visla Labs
Seed Round in 2018
Visla Labs Inc. is a San Francisco-based startup focused on developing an artificial intelligence platform tailored for the radiology and healthcare sectors. Incorporated in 2018, the company is dedicated to advancing healthcare technology, aiming to create innovative solutions that enhance diagnostic processes and patient care. With venture capital backing, Visla Labs is positioned for significant growth as it approaches a critical milestone in its development.
Bright Machines
Series A in 2018
Bright Machines, Inc. is a manufacturing company founded in 2018 and based in San Francisco, California, with additional offices in Tel Aviv, China, and Mexico. The company specializes in creating robotic arms and cells for micro factories, focusing on the assembly and inspection of electronic products. It aims to reduce manual labor in manufacturing by integrating advanced robotics with a software-defined manufacturing platform. This platform leverages artificial intelligence, machine learning, and production data to enhance automation processes, resulting in robots that are adaptable and equipped with sensor technology and computer vision. Bright Machines enables its clients to innovate rapidly and achieve better production yields at lower costs, meeting the evolving demands of the manufacturing sector.
Aeva
Series A in 2018
Aeva is a machine vision company that specializes in developing advanced optical-based sensors, particularly in the field of lidar technology, which is essential for autonomous vehicles. Founded in 2016 and headquartered in Mountain View, California, Aeva integrates vision, depth, and motion sensing into a single product that delivers superior performance regarding range, resolution, and velocity measurement under various weather conditions. Its proprietary Frequency Modulated Continuous Wave (FMCW) technology enables the creation of a 4D LiDAR-on-chip, which has applications beyond automated driving, including consumer electronics, health, industrial automation, and security. Aeva operates primarily in North America, EMEA, and Asia, with the majority of its revenue generated from the North American market.
Cape Analytics
Series B in 2018
Cape Analytics, LLC is a technology company that specializes in an artificial intelligence-based geospatial imagery data platform designed for the insurance and reinsurance sectors in the United States. Founded in 2014 and based in Mountain View, California, the company employs deep learning and computer vision to provide instant property intelligence, allowing insurers and property stakeholders to obtain critical property attributes during the underwriting process. This platform offers the precision and detail typically associated with on-site inspections, but with the added benefits of speed and extensive coverage. By streamlining access to valuable property data, Cape Analytics enhances the efficiency of underwriting for real estate and insurance companies.
Vium
Series B in 2018
Vium, Inc. is a biotechnology company focused on transforming preclinical research and enhancing animal welfare through the development of digital biomarkers. Fully accredited by AAALAC International, Vium has received commendation for its commitment to the principles of humane animal research. The company's platform, known as Digital Vivarium and Vium Cloud, integrates advanced technologies such as computer vision, artificial intelligence, and machine learning to non-invasively capture and analyze physiological metrics and behaviors. This innovative approach provides researchers across biotechnology, pharmaceutical, and academic sectors with accurate data that facilitates better decision-making regarding which compounds to advance to clinical trials. Founded in 2013 and headquartered in San Mateo, California, Vium aims to accelerate the preclinical drug discovery and development pipeline while ensuring ethical standards in research practices.
Arraiy
Series A in 2018
Arraiy, Inc. is a company based in Palo Alto, California, focused on developing an AI-driven production platform for the motion picture and television industry. Founded in 2016 and formerly known as opencv.ai, Arraiy utilizes computer vision and machine learning to enhance the filmmaking process. The company collaborates with major studios, industry veterans, and award-winning artists to innovate visual storytelling and integrate real and virtual worlds seamlessly. Through its platform, Arraiy aims to empower creators with greater creative freedom and redefine the standards of visual content production. As of July 2020, Arraiy operates as a subsidiary of Matterport, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.